Study Modifications and Primary Endpoint Reinterpretations Prior to FDA Approval of High-Risk Cardiovascular Devices

Presenter: Sanket S. Dhruva, Lucy H. Liu, Lisa A. Bero, Rita F. Redberg

REGISTER for free or LOG IN to view this content

Study Modifications and Primary Endpoint Reinterpretations Prior to FDA Approval of High-Risk Cardiovascular Devices

We Recommend